The strong performance of Elscint's CT product line paced thecompany to improved financial results for its second quarter (end-June).The Haifa vendor reported revenues for the quarter increasing21% to $66.1 million, compared to $54.7 million in the same
The strong performance of Elscint's CT product line paced thecompany to improved financial results for its second quarter (end-June).The Haifa vendor reported revenues for the quarter increasing21% to $66.1 million, compared to $54.7 million in the same perioda year ago.
The company's net income was up as well, to $4.9 million inthe most recent quarter, compared to $2.7 million in the secondquarter of 1995. Net income for the second quarter of 1995 includes$1.6 million from settlement of a patent dispute with Sopha Medical(SCAN 7/28/93).
Dr. Thomas Spackman, president of Elscint's U.S. subsidiary,said the numbers were paced by strong growth in internationalmarkets, as well as a good performance in CT both in the U.S.and globally.
"There has been a real resurgence in some of the markets,in Eastern and Western Europe, and to some extent North and SouthAmerica," Spackman said. "There is growth in rest ofthe world, and the U.S. is hanging on."
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.